The common treatments for T-lymphoblastic leukemia are chemotherapy and bone marrow transplantation. 1. Chemotherapy: commonly used chemotherapeutic drugs include cyclophosphamide, vincristine, anthracycline chemotherapeutic drugs (such as doxorubicin, epirubicin, pirenzolubicin, etc.). Through regular treatment, most patients have good results. In the later stage, methotrexate and other drugs can be applied to maintain the treatment, and then vincristine + epizootic erythromycin + menthylase + prednisone program can be applied to consolidate the treatment. 2. Bone marrow transplantation: Bone marrow transplantation can be carried out as early as possible for patients with conditions. It should be noted that T-lymphoblastic leukemia can be reduced through “early detection, early diagnosis, early treatment”, many patients are likely to survive for a long time, and it is recommended that patients set up the confidence in treatment, and standardize the treatment under the guidance of physicians.